Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

13 results
Display

Helicobacter pylori Eradication within 120 Days Is Associated with Decreased Complicated Recurrent Peptic Ulcers in Peptic Ulcer Bleeding Patients

Chang SS, Hu HY

BACKGROUND/AIMS: The connection between Helicobacter pylori and complicated peptic ulcer disease in peptic ulcer bleeding (PUB) patients taking nonsteroidal anti-inflammatory drugs has not been established. In this study, we sought...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Investigation of -308G>A and -1031T>C Polymorphisms in the TNFA Promoter Region in Polish Peptic Ulcer Patients

Salagacka , Zebrowska , Jelen A, Mirowski M, Balcerczak E

BACKGROUND/AIMS: Tumor necrosis factor alpha (TNF-alpha) encoded by TNFA is a key mediator in inflammation, a precursor condition for peptic ulceration. Promoter polymorphisms of TNFA that influence its transcriptional activity...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Helicobacter pylori Eradication Therapy in Korea

Kim SY, Jung SW

Helicobacter pylori (H. pylori) is known to be associated with many gastrointestinal diseases including peptic ulcer. In Korea, eradication of H. pylori is recommended for peptic ulcer disease, low grade...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Could Antibiotic Resistance Rate of Helicobacter pylori be Different according to Gastroduodenal Diseases?

Shin WG

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison between Endoscopic Therapy and Medical Therapy in Peptic Ulcer Patients with Adherent Clot: A Multicenter Prospective Observational Cohort Study

Kim SH, Jung JT, Kwon JG, Kim EY, Lee DW, Jeon SW, Park KS, Lee SH, Park JB, Ha CY, Park YS, Daegu-Gyeongbuk Gastrointestinal Study Group (DGSG)

BACKGROUND/AIMS: The optimal management of bleeding peptic ulcer with adherent clot remains controversial. The purpose of this study was to compare clinical outcome between endoscopic therapy and medical therapy. We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Management of portal hypertensive gastropathy and other bleeding

Chung WJ

A major cause of cirrhosis related morbidity and mortality is the development of variceal bleeding, a direct consequence of portal hypertension. Less common causes of gastrointestinal bleeding are peptic ulcers,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Primary Antibiotic Resistance of Helicobacter pylori Strains and Eradication Rate according to Gastroduodenal Disease in Korea

Kim JY, Kim N, Park HK, Jo HJ, Shin CM, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Nam RH, Kim JM, Lee JH, Jung HC, Song IS

BACKGROUND/AIMS: This study was performed to evaluate whether the prevalence rates of primary antibiotic resistance in Helicobacter pylori (H. pylori) isolates and the eradication rate of H. pylori could be...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Risk Factors for Upper Gastrointestinal Bleeding after Percutaneous Coronary Intervention: A Single-Center Study

Lee JM, Park SY, Choi JH, Kim UJ, Rew SJ, Cho JY, Ahn Y, Lim SW, Jun CH, Park CH, Kim HS, Choi SK, Rew JS

BACKGROUND/AIMS: Percutaneous coronary intervention (PCI) is often performed therapeutically, and antithrombotic treatment is required for at least 12 months after stent implantation. However, the development of post-PCI upper gastrointestinal bleeding...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Updated Guidelines 2012 for Gastroesophageal Reflux Disease

Jung HK, Hong SJ, Jo Y, Jeon SW, Cho YK, Lee KJ, Lee JS, Park HJ, Shin ES, Lee SH, Han SU, The Korean Society of Neurogastroenterology and Motility

In 2010, a Korean guideline for the management of gastroesophageal reflux disease (GERD) was made by the Korean Society of Neurogastroenterology and Motility, in which the definition and diagnosis of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Efficacy of Moxifloxacin-Containing Triple Therapy after Standard Triple, Sequential, or Concomitant Therapy Failure for Helicobacter pylori Eradication in Korea

Chung KH, Lee DH, Jin E, Cho Y, Seo JY, Kim N, Jeong SH, Kim JW, Hwang JH, Shin CM

BACKGROUND/AIMS: Retreatment after initial treatment failure for Helicobacter pylori is very challenging. The purpose of this study was to evaluate the efficacies of moxifloxacin-containing triple and bismuth-containing quadruple therapy. METHODS: A...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Guidelines for the Diagnosis and Treatment of Helicobacter pylori Infection in Korea, 2013 Revised Edition

Kim SG, Jung HK, Lee HL, Jang JY, Lee H, Kim CG, Shin WG, Shin ES, Lee YC, Korean College of Helicobacter and Upper Gastrointestinal Research

Since the Korean College of Helicobacter and Upper Gastrointestinal Research has first developed the guideline for the diagnosis and treatment of Helicobacter pylori infection in 1998, the revised guideline was...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy of Levofloxacin and Rifaximin based Quadruple Therapy in Helicobacter pylori Associated Gastroduodenal Disease: A Double-Blind, Randomized Controlled Trial

Choi KH, Chung WC, Lee KM, Paik CN, Kim EJ, Kang BK, Oak JH, Jung SH

The aim of this study was to evaluate the efficacy of levofloxacin and rifaximin based quadruple regimen as first-line treatment for Helicobacter pylori infection. A prospectively randomized, double-blinded, parallel group,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Aspirin Alone or Aspirin Plus Additional Antiplatelets Therapy on Upper Gastrointestinal Hemorrhage

Bae SE, Kim SE, Jung SA, Yoon SY, Shim KN, Jung HK, Kim TH, Yoo K, Moon IH

BACKGROUND/AIMS: The increasing incidence of cardiovascular disease has led to an increase in the frequency of upper gastrointestinal (GI) hemorrhage due to the use of antiplatelet agents. This study examined...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr